Skip to content
HowShorted

Sonnet BioTherapeutics Holdings, Inc. short interest in 2024

In 2024, Sonnet BioTherapeutics Holdings, Inc.'s disclosed short interest ran from 5.34% of shares outstanding on 12 Jan 2024 to 2.08% on 31 Dec 2024, a change of -3.26 percentage points. The year's high was 18.16% on 15 Mar 2024 and its low 0.67% on 13 Sep 2024, averaging 8.42% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 29.29 days on 30 Apr 2024. Full history: Sonnet BioTherapeutics Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Sonnet BioTherapeutics Holdings, Inc. in 2024

2024 in figures

Start of year
5.34% (12 Jan 2024)
End of year
2.08% (31 Dec 2024)
Change
-3.26 pp
High
18.16% (15 Mar 2024)
Low
0.67% (13 Sep 2024)
Average
8.42%
Highest days to cover
29.29 (30 Apr 2024)
SEC filings marked
8

Every report in 2024

Sonnet BioTherapeutics Holdings, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20245.34%3.34
31 Jan 20245.45%11.71
15 Feb 20247.56%5.2110-Q filed, results (8-K)
29 Feb 20248.28%2.75
15 Mar 202418.16%1.57
28 Mar 202414.73%5.79
15 Apr 202413.82%16.70
30 Apr 202413.04%29.29
15 May 202413.12%23.6710-Q filed, results (8-K)
31 May 202411.06%10.29
14 Jun 202410.88%14.96
15 Aug 20241.26%1.0010-Q filed, results (8-K)
30 Aug 20240.85%1.00
13 Sep 20240.67%1.00
31 Dec 20242.08%1.0010-K filed, results (8-K)

See also: Sonnet BioTherapeutics Holdings, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.